Ozempic reduces risk of serious illness and death in people

Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and chronic kidney

Related Keywords

United States , Denmark , Sydney , New South Wales , Australia , Danish , American , Katherine Tuttle , Martin Holst Lange , Vlado Perkovic , European Renal Association Congress , University Of Washington , Institute Of Translational Health Sciences , Providence Inland Northwest Health , Novo Nordisk , University Of New South Wales Sydney , Us Centers For Disease , Disease Control , New England Journal , Diabetic Kidney Disease Collaborative , American Society , Translational Health Sciences , American Indian ,